# Comparison of Olopatadine 0.6% and Fluticasone Proprionate 50mcg Nasal Sprays in a Two Week Seasonal Allergic Rhinitis Trial

> **NCT00691665** · PHASE4 · COMPLETED · sponsor: **Alcon Research** · enrollment: 130 (actual)

## Conditions studied

- Seasonal Allergic Rhinitis

## Interventions

- **DRUG:** Olopatadine HCL Nasal Spray, 0.6%
- **DRUG:** Fluticasone Propionate Nasal Spray, 50 mcg

## Key facts

- **NCT ID:** NCT00691665
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2009-01
- **Final completion:** —
- **Target enrollment:** 130 (ACTUAL)
- **Last updated:** 2010-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00691665

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00691665, "Comparison of Olopatadine 0.6% and Fluticasone Proprionate 50mcg Nasal Sprays in a Two Week Seasonal Allergic Rhinitis Trial". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00691665. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*